Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,942 | 551 | 96.0% |
| Travel and Lodging | $416.11 | 2 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,599 | 105 | $0 (2024) |
| Novo Nordisk Inc | $1,387 | 87 | $0 (2024) |
| Lilly USA, LLC | $1,087 | 64 | $0 (2024) |
| Abbott Laboratories | $948.48 | 12 | $0 (2024) |
| Amgen Inc. | $773.95 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $765.78 | 46 | $0 (2024) |
| PFIZER INC. | $521.53 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $430.89 | 26 | $0 (2024) |
| Inspire Medical Systems, Inc. | $305.45 | 13 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $268.23 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,396 | 131 | ABBVIE INC. ($339.05) |
| 2023 | $1,972 | 114 | ABBVIE INC. ($388.63) |
| 2022 | $2,279 | 133 | ABBVIE INC. ($468.63) |
| 2021 | $1,726 | 98 | Novo Nordisk Inc ($368.27) |
| 2020 | $818.04 | 52 | Novo Nordisk Inc ($175.12) |
| 2019 | $275.88 | 16 | Amgen Inc. ($152.01) |
| 2018 | $17.73 | 1 | Merck Sharp & Dohme Corporation ($17.73) |
| 2017 | $873.98 | 8 | Abbott Laboratories ($873.98) |
All Payment Transactions
553 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Hematology | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $0.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Obesity | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: NEUROLOGY | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Hyperthyroidism | ||||||
| 10/28/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $43.49 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.32 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,491 | 2,420 | $344,054 | $123,698 |
| 2022 | 18 | 651 | 888 | $134,109 | $51,426 |
| 2021 | 8 | 181 | 202 | $29,673 | $14,942 |
| 2020 | 2 | 29 | 29 | $2,935 | $1,787 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 438 | $105,996 | $39,914 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 99 | 99 | $17,523 | $12,550 | 71.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 79 | $25,280 | $10,552 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 149 | $25,479 | $9,690 | 38.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 25 | 144 | $35,568 | $7,211 | 20.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 85 | 85 | $16,937 | $6,668 | 39.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $7,773 | $4,785 | 61.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 22 | 155 | $18,428 | $4,690 | 25.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 25 | 102 | $14,924 | $3,777 | 25.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 45 | 45 | $4,437 | $3,162 | 71.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $12,342 | $3,155 | 25.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 18 | 60 | $9,011 | $2,222 | 24.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,068 | $2,124 | 69.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 116 | 116 | $3,132 | $2,102 | 67.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 100 | 100 | $2,700 | $1,810 | 67.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 42 | 51 | $10,425 | $1,731 | 16.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 40 | 93 | $6,231 | $1,476 | 23.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 49 | 49 | $1,813 | $1,465 | 80.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 115 | $7,705 | $1,247 | 16.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 30 | 30 | $1,140 | $763.00 | 66.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $920.00 | $610.40 | 66.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 178 | 270 | $5,400 | $592.30 | 11.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 57 | $3,933 | $536.75 | 13.6% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 12 | 12 | $1,731 | $361.50 | 20.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 16 | 17 | $646.00 | $243.00 | 37.6% |
About Benjamin Morrison
Benjamin Morrison is a Family Medicine healthcare provider based in Suwanee, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1073977781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Benjamin Morrison has received a total of $10,358 in payments from pharmaceutical and medical device companies, with $2,396 received in 2024. These payments were reported across 553 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($9,942).
As a Medicare-enrolled provider, Morrison has provided services to 2,352 Medicare beneficiaries, totaling 3,539 services with total Medicare billing of $191,852. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Suwanee, GA
- Active Since 04/08/2016
- Last Updated 04/16/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073977781
Products in Payments
- UBRELVY (Drug) $885.74
- Mitra Clip system (Device) $865.99
- MOUNJARO (Drug) $627.90
- NURTEC ODT (Drug) $617.07
- TRELEGY ELLIPTA (Drug) $541.79
- Ozempic (Drug) $526.90
- Aimovig (Biological) $481.83
- JARDIANCE (Drug) $381.91
- INSPIRE (Device) $305.45
- QULIPTA (Drug) $304.27
- Rybelsus (Drug) $292.70
- VRAYLAR (Drug) $244.31
- FARXIGA (Drug) $169.57
- RYBELSUS (Drug) $162.04
- Wegovy (Drug) $154.97
- AIRSUPRA (Drug) $152.05
- Otezla (Drug) $137.60
- Dexcom G6 Transmitter (Medical Supply) $134.07
- ACCRUFER (Drug) $132.63
- Saxenda (Drug) $132.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Suwanee
Bede Soon Cha, D.o, D.O
Family Medicine — Payments: $11,205
Sharmin Banu Anam, M.d, M.D
Family Medicine — Payments: $10,648
Khushbuben Patel, M.d, M.D
Family Medicine — Payments: $6,509
Dr. Scott Griffith, Md, MD
Family Medicine — Payments: $5,982
Mr. Myong Kang, Md, MD
Family Medicine — Payments: $4,760
Dr. Anila Jamal, M.d, M.D
Family Medicine — Payments: $2,822